The Marcel van den Brink Lab

The van den Brink Lab

Allogeneic hematopoietic stem cell transplantation (HSCT) is an important therapy for a variety of cancers, including leukemias, lymphomas, and myeloma. Several complications limit its use, including relapse of malignancy, graft-versus-host disease, and prolonged immune depletion caused by the conditioning required for successful transplantation — all of which can lead to increased morbidity and mortality after allo-HSCT. My laboratory studies clinically relevant problems in HSCT and aims to develop novel therapeutic strategies to improve patient outcome.

Learn more Arrow rightAn icon showing an arrow pointing to the right.
Pictured: Marcel R. M. van den Brink

Marcel R. M. van den Brink, MD, PhD


Research Focus

Physician-scientist Marcel R. M. van den Brink studies the immunology of bone marrow transplantation with a particular focus on intestinal microbiome and strategies to enhance thymus and immune reconstitution


MD, PhD, Universiteit Leiden